WELL Health Technologies Corp.

TSX:WELL.TO

Medical - Care Facilities

Healthcare
$3.70 +0.34%

+$0.02 today

Market cap
$947.00M
Beta
1.33
P/E (TTM)
41.6
EPS (TTM)
$0.11
52W Low $3.58High $6.08

Volume 2.80M

Average 1.62M

WELL.TO Common Stock Repurchased

Cash spent buying back the company's own shares.

WELL Health Technologies Corp.TSX: WELL.TO

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased growth accelerates

Q1 FY2026 common stock repurchased of CA$713K (cash outflow) rose 151.9% year over year, ahead of the -5.4% change in trailing-twelve-month common stock repurchased. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at +95.9% a year.

Context

  • Common stock repurchased amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Common stock repurchased increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +151.9% holds above the trailing-twelve-month pace of -5.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$713K+1.4% QoQ
Last fiscal yearDec 2025
-CA$1.83M+10.1% YoY
LTMMar 2026
-CA$2.26M-5.4% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+151.9%——
1 year+10.1%——
3-year CAGR+95.9%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

CAD · from the cash flow

Latest · FY2025
(1.83M) CAD
Year-over-year change
-10.1%

Common Stock Repurchased vs competitors

How WELL.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.4% is the highest of 2, against a peer median of -61.3%.
  • Common stock repurchased amounts to 0.2% of revenue for WELL.TO, versus a peer median of 3.8%.
WELL.TO Competitors
Common Stock Repurchased for WELL.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRON.TOCronos Group Inc.LTM Mar 2026$26.27M USD—+51.4%16.5%
DR.TOMedical Facilities CorporationLTM Mar 2026$23.44M USD-61.3%+19.1%7.7%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$2.26M CAD-5.4%+95.9%0.2%
EXE.TOExtendicare Inc.LTM Jun 2026CA$0 CAD——0.0%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$0 CAD——0.0%
Peer median (excluding WELL.TO) —-61.3%+35.2%3.8%

Competitors are the stored peer set for WELL.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(30.9M)18.68M82K29.1M4.46M
Depreciation & Amortization38.22M55.2M60.77M72.31M93.76M
Deferred Income Tax1.04M(978K)(10.42M)(31.62M)(16.38M)
Stock-Based Compensation21.01M24.48M26.16M15.27M22.69M
Change in Working Capital(11.2M)(6.06M)(10.25M)6.67M(36.7M)
Accounts Receivables(13.27M)(9.37M)(2.49M)(80.25M)47.3M
Inventory876K(577K)190K(1.51M)231K
Accounts Payables1.6M10.55M(9.21M)36.42M(20.12M)
Other Working Capital(399K)(6.67M)1.26M52.02M(64.12M)
Other Non-Cash Items4.1M(14.78M)95K(82.21M)47.96M
Operating Cash Flow22.27M76.55M66.44M9.52M115.79M
Capital Expenditures(2.68M)(6.4M)(25.38M)(16.23M)(27.87M)
Acquisitions (Net)(421.76M)(31.13M)(72.78M)(37.27M)(80.51M)
Purchases of Investments(3.12M)(16.51M)0(73K)0
Sales of Investments3.12M16.51M11.56M2.39M15.1M
Other Investing Activities(75.33M)(396K)(19.82M)(9.05M)(18.47M)
Investing Cash Flow(499.78M)(37.93M)(106.42M)(60.23M)(111.74M)
Debt Repayment171.07M(58.75M)38.77M(49.34M)157.6M
Common Stock Issued302.5M34.51M810K3.22M445K
Common Stock Repurchased0(243K)0(1.66M)(1.83M)
Dividends Paid00000
Other Financing Activities(21.04M)6.15M(28.14M)136.85M(155.28M)
Financing Cash Flow452.53M(52.85M)10.63M133.5M941K
Effect of Forex Changes9K1.22M(532K)4.75M(2.91M)
Net Change in Cash(24.97M)(13.01M)(5.49M)88.25M2.09M
Free Cash Flow19.59M70.14M37.2M(6.7M)87.92M

WELL Health Technologies Corp.

TSX:WELL.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.